All About Positive Health

Just another Blog Engage Bloggers Club weblog

  • RSS ClinicianOnNet

    • Links for 2012-01-31 [Digg] February 1, 2012
      Bedsores can be Responsible for Considerable Morbidity and Mortality Bedsores can kill almost as many as the hospital superbug MRSA (Methicillin Resistant Staphylococcus Aureus) and cost a lot to the exchequer anywhere in the world. Even when they don’t kill, they inflict terrible pain, discomfort; and rob the sufferer of their time and money. Read more; htt […]
    • Bedsores can be Responsible for Considerable Morbidity and Mortality January 31, 2012
      Bedsores can kill almost as many as the hospital superbug MRSA (Methicillin Resistant Staphylococcus Aureus) and cost a lot to the exchequer anywhere in the world. Even when they don’t kill, they... [[ This is a content summary only. Visit my website for full links, other content, and more! ]] […]
    • Links for 2012-01-30 [Digg] January 31, 2012
      Melatonin and Risk of Developing Diabetes Mellitus In addition to inducing sleep, it also acts on different organs of body and influence their functions too. So it regulates the “biological clock” responsible for sleep/wake pattern. It has been seen that people engaged in night shift duty are prone to develop type II diabetes (DM Type II) mellitus, obesity a […]
  • Get it Delivered to YOU.

    Enter your email address:

    Delivered by FeedBurner

  • Recent Comments

  • Meta


  • 0
    Unique
    Visitors
    Powered By Google Analytics
  • Pages

  • Recently Active Member Avatars

    Member avatar
    Member avatar
    Member avatar
    Member avatar
    Member avatar

Febuxostat and Allopurinol Combination Works Better in Gout

Posted by Dr.Prahallad Panda on June 21, 2010

Gout, an arthritic disease having hall mark of affecting the metatarsophalangeal (MTP) joint, the joint of great toe to the foot; is very painful. Colchicine is the specific drug in acurte phase along with a NSAID such as naproxen. In long term allopurinol is used. The target is to get the urate (Uric acid ) level something below 6mg%. Now researcher say combining a newer drug febuxostat may give better result, though disease flares may not reduce.
Another experimental monoclonal antibody, Canakinumab addition may decrease the flares; said the researchers.
clipped from www.medpagetoday.com
ROME — Gout patients treated with febuxostat (Uloric) at a dose of 80 mg or 120 mg daily saw greater declines in serum urate levels than those treated with allopurinol 300 mg, researchers said here.

At the patients’ final clinic visit, 75% of those treated with febuxostat 80 mg/day achieved urate-lowering to a goal of less than 6 mg/dl, but only 38% of patients taking allopurinol 300 mg/day achieved that goal (P<0.001), according to Michael Becker, MD, of the University of Chicago.

When the researchers looked a further urate lowering, they found that 65% of those on the higher febuxostat dose achieved a serum urate level below 5 mg/day, as did 47% on the lower febuxostat dose and just 13% on allopurinol. The differences between both febuxostat treatment groups and the allopurinol group were again significant at P<0.001.

Despite lower serum urate levels, no differences were observed between treatments for gout flares or reduction of tophi.

  blog it

Leave a Reply



XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>